SEC Form 4 · accession 0001209191-17-003672
Minerva Neurosciences, Inc. · NERV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph H. Reilly
Officer — SVP & Chief Operating Officer
Period of report
Jan 11, 2017
Accepted (ET)
Jan 13, 2017 · 4:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001598646
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 11, 2017 | M | 1,600 | $4.71 | A | 9,933 | D | |
| Common Stock | Jan 11, 2017 | S | 1,600 | $12.03 | D | 8,333 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $4.71 | Jan 11, 2017 | M | 1,600 | D | — | Dec 3, 2025 | Common Stock | 1,600 | 67,400 | D |
Explanation of responses
- F1These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2016.
- F2This option shall vest as follows: 25% vested December 14, 2016 and then in quarterly installments over 3 years thereafter.